{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:21:21Z","timestamp":1783354881736,"version":"3.54.6"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"A project grant from the GSK Africa Non-Communicable Disease Open Lab"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04317-9","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:53:13Z","timestamp":1777269193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment response and determinants of asthma control in Eastern Africa"],"prefix":"10.1186","volume":"26","author":[{"given":"Kefyalew Ayalew","family":"Getahun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nega Berhane","family":"Tessema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winters","family":"Muttamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levicatus","family":"Mugenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Chakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amsalu","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Mequanente","family":"Abay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaye B.","family":"Mersha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getnet","family":"Yimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Kirenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"4317_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30363-5","author":"ZW El-Husseini","year":"2020","unstructured":"El-Husseini ZW, Gosens R, Dekker F, Koppelman GH. The genetics of asthma and the promise of genomics-guided drug target discovery. Lancet Respir Med. 2020. https:\/\/doi.org\/10.1016\/S2213-2600(20)30363-5.","journal-title":"Lancet Respir Med"},{"key":"4317_CR2","unstructured":"Global Initiative for Global strategy for asthma management and prevention 2017. Available from: www.ginasthma.org."},{"issue":"5","key":"4317_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jaci.2010.07.019","volume":"126","author":"J Bousquet","year":"2010","unstructured":"Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the world health organization consultation on severe asthma. J Allergy Clin Immunol. 2010;126(5):926\u201338.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"4317_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343\u201373.","journal-title":"Eur Respir J"},{"issue":"5","key":"4317_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/thorax-2024-222679","volume":"80","author":"E Bae","year":"2025","unstructured":"Bae E, Park HJ, Park H, Lee JK, Heo EY, Lee CH, et al. Early clinical remission and its role in lung function decline and exacerbation in adult Korean patients with asthma. Thorax. 2025;80(5):273\u201382.","journal-title":"Thorax"},{"issue":"2","key":"4317_CR6","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S2214-109X(22)00506-X","volume":"11","author":"L Garcia-Marcos","year":"2023","unstructured":"Garcia-Marcos L, Chiang CY, Asher MI, Marks GB, El Sony A, Masekela R, et al. Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study. Lancet Glob Health. 2023;11(2):e218\u201328.","journal-title":"Lancet Glob Health"},{"key":"4317_CR7","doi-asserted-by":"publisher","first-page":"101301","DOI":"10.1016\/j.smim.2019.101301","volume":"46","author":"I Agache","year":"2019","unstructured":"Agache I. Severe asthma phenotypes and endotypes. Semin Immunol. 2019;46:101301.","journal-title":"Semin Immunol"},{"issue":"2","key":"4317_CR8","doi-asserted-by":"publisher","first-page":"100870","DOI":"10.1016\/j.waojou.2024.100870","volume":"17","author":"S Zewdie","year":"2024","unstructured":"Zewdie S, Mekuria B, Alemu BK, Bayked EM, NurAhmed Toleha H, Ayenew W, et al. Prevalence of medication adherence among adult asthmatic patients in four African countries: a systematic review and meta-analysis. World Allergy Organ J. 2024;17(2):100870.","journal-title":"World Allergy Organ J"},{"issue":"1","key":"4317_CR9","doi-asserted-by":"publisher","first-page":"e0262566","DOI":"10.1371\/journal.pone.0262566","volume":"17","author":"T Mulugeta","year":"2022","unstructured":"Mulugeta T, Ayele T, Zeleke G, Tesfay G. Asthma control and its predictors in Ethiopia: systematic review and meta-analysis. PLoS ONE. 2022;17(1):e0262566.","journal-title":"PLoS ONE"},{"issue":"1","key":"4317_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12875-023-02030-8","volume":"24","author":"J Chakaya","year":"2023","unstructured":"Chakaya J, Mecha J, Beekman M. Over-prescription of short-acting beta(2)-agonists remains a serious health concern in Kenya: results from the SABINA III study. BMC Prim Care. 2023;24(1):141.","journal-title":"BMC Prim Care"},{"issue":"3","key":"4317_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5588\/ijtld.13.0699","volume":"18","author":"AN Serugendo","year":"2014","unstructured":"Serugendo AN, Kirenga BJ, Hawkes M, Nakiyingi L, Worodria W, Okot-Nwang M. Evaluation of asthma control using global initiative for asthma criteria and the asthma control test in Uganda. Int J Tuberc Lung Dis. 2014;18(3):371\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4317_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000484","author":"B Kirenga","year":"2020","unstructured":"Kirenga B, Chakaya J, Yimer G, Nyale G, Haile T, Muttamba W, et al. Phenotypic characteristics and asthma severity in an East African cohort of adults and adolescents with asthma: findings from the African severe asthma project. BMJ Open Respir Res. 2020. https:\/\/doi.org\/10.1136\/bmjresp-2019-000484.","journal-title":"BMJ Open Respir Res"},{"key":"4317_CR13","doi-asserted-by":"crossref","unstructured":"Oh J, Kim S, Kim MS, Abate YH, Abd ElHafeez S, Abdelkader A, et al. Global, regional, and national burden of asthma and atopic dermatitis, 1990\u20132021, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Respir Med. 2025;13(5):425\u201346.","DOI":"10.1016\/S2213-2600(25)00003-7"},{"issue":"2","key":"4317_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1124\/pr.110.003533","volume":"63","author":"Q Ma","year":"2011","unstructured":"Ma Q, Lu AY. Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev. 2011;63(2):437\u201359.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"4317_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jaci.2021.12.765","volume":"149","author":"S Al Heialy","year":"2022","unstructured":"Al Heialy S, Ramakrishnan RK, Hamid Q. Recent advances in the immunopathogenesis of severe asthma. J Allergy Clin Immunol. 2022;149(2):455\u201365.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"4317_CR16","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1164\/rccm.201712-2529OC","volume":"197","author":"ACY Mak","year":"2018","unstructured":"Mak ACY, White MJ, Eckalbar WL, Szpiech ZA, Oh SS, Pino-Yanes M, et al. Whole-genome sequencing of pharmacogenetic drug response in racially diverse children with asthma. Am J Respir Crit Care Med. 2018;197(12):1552\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"4317_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111684","author":"FLM Ricciardolo","year":"2021","unstructured":"Ricciardolo FLM, Sprio AE, Baroso A, Gallo F, Riccardi E, Bertolini F, et al. Characterization of T2-Low and T2-High asthma phenotypes in real-life. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9111684.","journal-title":"Biomedicines"},{"issue":"5","key":"4317_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.23822\/EurAnnACI.1764-1489.304","volume":"55","author":"MB Bilo","year":"2023","unstructured":"Bilo MB, Martini M, Antonicelli L, Aliani M, Carone M, Cecchi L, et al. Severe asthma: follow-up after one year from the Italian Registry on Severe Asthma (IRSA). Eur Ann Allergy Clin Immunol. 2023;55(5):199\u2013211.","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"1","key":"4317_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41533-023-00336-9","volume":"33","author":"S Zhang","year":"2023","unstructured":"Zhang S, White J, Hunter AG, Hinds D, Fowler A, Gardiner F, et al. Suboptimally controlled asthma in patients treated with inhaled ICS\/LABA: prevalence, risk factors, and outcomes. NPJ Prim Care Respir Med. 2023;33(1):19.","journal-title":"NPJ Prim Care Respir Med"},{"key":"4317_CR20","doi-asserted-by":"publisher","first-page":"105859","DOI":"10.1016\/j.rmed.2019.105859","volume":"162","author":"R Buhl","year":"2020","unstructured":"Buhl R, Heaney LG, Loefroth E, Larbig M, Kostikas K, Conti V, et al. One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta(2)-agonist in UK primary care settings. Respir Med. 2020;162:105859.","journal-title":"Respir Med"},{"key":"4317_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-031-32259-4_7","volume":"1426","author":"T Maeda","year":"2023","unstructured":"Maeda T, Khurana S. Heterogeneity of treatment response to asthma. Adv Exp Med Biol. 2023;1426:143\u201361.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"4317_CR22","doi-asserted-by":"publisher","first-page":"100209","DOI":"10.1016\/j.jacig.2024.100209","volume":"3","author":"BJ Kirenga","year":"2024","unstructured":"Kirenga BJ, Chakaya J, Yimer G, Nyale G, Haile T, Muttamba W, et al. The burden of severe asthma in sub-Saharan Africa: findings from the African severe asthma project. J Allergy Clin Immunol Glob. 2024;3(2):100209.","journal-title":"J Allergy Clin Immunol Glob"},{"key":"4317_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2020.100130","author":"R Kwizera","year":"2020","unstructured":"Kwizera R, Wadda V, Mugenyi L, Aanyu-tukamuhebwa H, Nyale G, Yimer G, et al. Skin prick reactivity among asthmatics in East Africa. World Allergy Organ J. 2020. https:\/\/doi.org\/10.1016\/j.waojou.2020.100130.","journal-title":"World Allergy Organ J"},{"key":"4317_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/20406223231190480","author":"B Ragnoli","year":"2023","unstructured":"Ragnoli B, Radaeli A, Pochetti P, Kette S, Morjaria J, Malerba M. Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases. Ther Adv Chronic Dis. 2023. https:\/\/doi.org\/10.1177\/20406223231190480.","journal-title":"Ther Adv Chronic Dis"},{"key":"4317_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12071093","author":"K Porpodis","year":"2022","unstructured":"Porpodis K, Tsiouprou I, Apostolopoulos A, Ntontsi P, Fouka E, Papakosta D, et al. Eosinophilic asthma, phenotypes-endotypes and current biomarkers of choice. J Pers Med. 2022. https:\/\/doi.org\/10.3390\/jpm12071093.","journal-title":"J Pers Med"},{"issue":"2","key":"4317_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"key":"4317_CR27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01499-2021","author":"S Stanojevic","year":"2022","unstructured":"Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS\/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022. https:\/\/doi.org\/10.1183\/13993003.01499-2021.","journal-title":"Eur Respir J"},{"issue":"12","key":"4317_CR28","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1513\/AnnalsATS.201901-030OC","volume":"16","author":"JE Hansen","year":"2019","unstructured":"Hansen JE, Dilektasli AG, Porszasz J, Stringer WW, Pak Y, Rossiter HB, et al. A new bronchodilator response grading strategy identifies distinct patient populations. Ann Am Thorac Soc. 2019;16(12):1504\u201317.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"4317_CR29","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/jim-2020-001663","volume":"69","author":"OC Ioachimescu","year":"2021","unstructured":"Ioachimescu OC, Ramos JA, Hoffman M, McCarthy K, Stoller JK. Assessing bronchodilator response by changes in per cent predicted forced expiratory volume in one second. J Investig Med. 2021;69(5):1027\u201334.","journal-title":"J Investig Med"},{"issue":"4","key":"4317_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","volume":"100","author":"EF Juniper","year":"2006","unstructured":"Juniper EF, Bousquet J, Abetz L, Bateman ED, Committee G. Identifying \u201cwell-controlled\u201d and \u201cnot well-controlled\u201d asthma using the Asthma Control Questionnaire. Respir Med. 2006;100(4):616\u201321.","journal-title":"Respir Med"},{"issue":"11","key":"4317_CR31","doi-asserted-by":"publisher","first-page":"e0187139","DOI":"10.1371\/journal.pone.0187139","volume":"12","author":"SJ Moon","year":"2017","unstructured":"Moon SJ, Lee WY, Hwang JS, Hong YP, Morisky DE. Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky medication adherence scale-8. PLoS ONE. 2017;12(11):e0187139.","journal-title":"PLoS ONE"},{"issue":"11","key":"4317_CR32","doi-asserted-by":"publisher","first-page":"e0187835","DOI":"10.1371\/journal.pone.0187835","volume":"12","author":"A Janezic","year":"2017","unstructured":"Janezic A, Locatelli I, Kos M. Criterion validity of 8-item Morisky medication adherence scale in patients with asthma. PLoS ONE. 2017;12(11):e0187835.","journal-title":"PLoS ONE"},{"issue":"26","key":"4317_CR33","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486\u201396.","journal-title":"N Engl J Med"},{"issue":"1","key":"4317_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12890-019-0998-0","volume":"19","author":"TC Chan","year":"2019","unstructured":"Chan TC, Hu TH, Chu YH, Hwang JS. Assessing effects of personal behaviors and environmental exposure on asthma episodes: a diary-based approach. BMC Pulm Med. 2019;19(1):231.","journal-title":"BMC Pulm Med"},{"key":"4317_CR35","unstructured":"Lawrence Mensah Agbota, Abraham Nsiah, Abubakari S. Evaluating the effectiveness of asthma treatments over time: a comparative analysis using repeated measure models and multilevel models of longitudinal data clinical case reports and studies 2023;7(2) : 1-13 ."},{"key":"4317_CR36","doi-asserted-by":"crossref","unstructured":"Brooks ME, Kristensen K, Benthem KJv, Magnusson A, Berg CW, Nielsen A, et al. glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling. R J. 2017;9(2):378\u2013400.","DOI":"10.32614\/RJ-2017-066"},{"issue":"1","key":"4317_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12911-022-02030-1","volume":"22","author":"T Ludden","year":"2022","unstructured":"Ludden T, O\u2019Hare K, Shade L, Reeves K, Patterson CG, Tapp H. Implementation of Coach McLungs<sc>(SM)<\/sc> into primary care using a cluster randomized stepped wedge trial design. BMC Med Inform Decis Mak. 2022;22(1):285.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"4317_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12874-020-00936-w","volume":"20","author":"ML Miller","year":"2020","unstructured":"Miller ML, Roe DJ, Hu C, Bell ML. Power difference in a chi<sc>(2)<\/sc> test vs generalized linear mixed model in the presence of missing data - a simulation study. BMC Med Res Methodol. 2020;20(1):50.","journal-title":"BMC Med Res Methodol"},{"key":"4317_CR39","first-page":"167","volume":"3","author":"AA Cruz","year":"2010","unstructured":"Cruz AA, Souza-Machado A, Franco R, Souza-Machado C, Ponte EV, Santos PM, et al. The impact of a program for control of asthma in a low-income setting. WAO J. 2010;3:167\u201374.","journal-title":"WAO J."},{"issue":"12","key":"4317_CR40","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1164\/rccm.201810-1868CI","volume":"199","author":"R Beasley","year":"2019","unstructured":"Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID. Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology. Am J Respir Crit Care Med. 2019;199(12):1471\u20137.","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"4317_CR41","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","volume":"157","author":"E Wang","year":"2020","unstructured":"Wang E, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, et al. Characterization of severe asthma worldwide: data from the international severe asthma registry. Chest. 2020;157(4):790\u2013804.","journal-title":"Chest"},{"issue":"1","key":"4317_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.chest.2024.02.029","volume":"166","author":"TY Lee","year":"2024","unstructured":"Lee TY, Price D, Yadav CP, Roy R, Lim LHM, Wang E, et al. International variation in severe exacerbation rates in patients with severe asthma. Chest. 2024;166(1):28\u201338.","journal-title":"Chest"},{"issue":"4","key":"4317_CR43","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4168\/aair.2015.7.4.312","volume":"7","author":"ML Kowalski","year":"2015","unstructured":"Kowalski ML, Makowska JS. Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice? Allergy Asthma Immunol Res. 2015;7(4):312\u201320.","journal-title":"Allergy Asthma Immunol Res"},{"key":"4317_CR44","doi-asserted-by":"crossref","unstructured":"Vahatalo I, Ilmarinen P, Tuomisto LE, Tommola M, Niemela O, Lehtimaki L, et al. 12-year adherence to inhaled corticosteroids in adult-onset asthma. ERJ Open Res. 2020;6(1):1\u201310.","DOI":"10.1183\/23120541.00324-2019"},{"key":"4317_CR45","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2147\/PPA.S209532","volume":"13","author":"M George","year":"2019","unstructured":"George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Prefer Adherence. 2019;13:1325\u201334.","journal-title":"Patient Prefer Adherence"},{"key":"4317_CR46","doi-asserted-by":"crossref","unstructured":"Bourdin A, Bjermer L, Brightling C, Brusselle GG, Chanez P, Chung KF, et al. ERS\/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. Eur Respir J. 2019;54(3):1\u201325.","DOI":"10.1183\/13993003.00900-2019"},{"issue":"1","key":"4317_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s13104-017-2887-z","volume":"10","author":"TH Gebremariam","year":"2017","unstructured":"Gebremariam TH, Binegdie AB, Mitiku AS, Ashagrie AW, Gebrehiwot KG, Huluka DK, et al. Level of asthma control and risk factors for poor asthma control among clinic patients seen at a Referral Hospital in Addis Ababa, Ethiopia. BMC Res Notes. 2017;10(1):558.","journal-title":"BMC Res Notes"},{"key":"4317_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.rmed.2018.03.024","volume":"138","author":"H Tarraf","year":"2018","unstructured":"Tarraf H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, Haouichat H, Khassawneh B, et al. Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study. Respir Med. 2018;138:64\u201373.","journal-title":"Respir Med"},{"issue":"2","key":"4317_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaip.2022.11.030","volume":"11","author":"R Beasley","year":"2023","unstructured":"Beasley R, Kankaanranta H. Inhaled corticosteroids in asthma: when less is more. J Allergy Clin Immunol Practice. 2023;11(2):544\u20135.","journal-title":"J Allergy Clin Immunol Practice."},{"issue":"12","key":"4317_CR50","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1164\/rccm.201910-1934CI","volume":"201","author":"R Beasley","year":"2020","unstructured":"Beasley R, Braithwaite I, Semprini A, Kearns C, Weatherall M, Pavord ID. Optimal asthma control: time for a new target. Am J Respir Crit Care Med. 2020;201(12):1480\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4317_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bcp.12637","volume":"80","author":"PT Daley-Yates","year":"2015","unstructured":"Daley-Yates PT. Inhaled corticosteroids: potency, dose equivalence and therapeutic index. Br J Clin Pharmacol. 2015;80(3):372\u201380.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"4317_CR52","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s12325-024-02823-y","volume":"41","author":"PT Daley-Yates","year":"2024","unstructured":"Daley-Yates PT, Aggarwal B, Plank M. Pharmacological basis of differences in dose response, dose equivalence, and duration of action of inhaled corticosteroids. Adv Ther. 2024;41(5):1995\u20132009.","journal-title":"Adv Ther"},{"issue":"1","key":"4317_CR53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2008.09.035","volume":"123","author":"M Thomas","year":"2009","unstructured":"Thomas M, von Ziegenweidt J, Lee AJ, Price D. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study. J Allergy Clin Immunol. 2009;123(1):116\u201321.","journal-title":"J Allergy Clin Immunol"},{"key":"4317_CR54","doi-asserted-by":"crossref","unstructured":"Marques L, Costa B, Pereira M, Silva A, Santos J, Saldanha L, et al. advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics. 2024;16(3):1\u201339.","DOI":"10.3390\/pharmaceutics16030332"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04317-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:12:58Z","timestamp":1783354378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04317-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04317-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from each country namely: Mulago Hospital Research and Ethics Committee (MHREC 875), the Uganda National Council for Science and Technology, the Institutional Review Board of Addis Ababa University (AAUMF\u201101\u2011008), the Kenyatta National Hospital\u2013University of Nairobi Ethics Review Committee (327\/04\/2016), and the Institutional Ethical Review Board of the University of Gondar (CMHSSH-UOG IRERC 32\/7\/2024). This study adhered to the ethical principles outlined in the Declaration of Helsinki, and all patient information was handled with full confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form (including identifiable images or personal clinical details).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}